| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
109,470,000 |
| Market
Cap: |
111.66(M) |
| Last
Volume: |
627,989 |
Avg
Vol: |
626,253 |
| 52
Week Range: |
$0.5601 - $1.41 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaxart is a clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology proprietary oral vaccine platform. Co.'s oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Co.'s investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. In addition, Co. is in early development of its first therapeutic vaccine targeting cervical cancer and dysplasia caused by human papillomavirus.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
25,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$31,240 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
10% Owner |
– – • |
2019-09-27 |
4 |
B |
$0.29 |
$282,066 |
D/D |
972,643 |
22,399,624 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2019-09-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,666,667 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2019-09-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,666,667 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2019-09-26 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
21,426,981 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2019-09-26 |
4 |
B |
$0.28 |
$1,332,888 |
D/D |
4,760,314 |
21,426,981 |
2.45 |
- |
|
| Finney Michael J. |
Director |
• • – |
2019-04-11 |
4 |
B |
$1.10 |
$200,000 |
D/D |
181,818 |
452,572 |
2.39 |
- |
|
| Tucker Sean |
Chief Scientific Officer |
• • – |
2019-04-11 |
4 |
B |
$1.10 |
$30,000 |
I/I |
27,273 |
52,661 |
1.99 |
- |
|
| Finney Michael J. |
Director |
– • – |
2018-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
34,958 |
270,754 |
|
- |
|
| Harland John M |
Chief Financial Officer |
• – – |
2018-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
761 |
761 |
|
- |
|
| Finney Michael J. |
Director |
– • – |
2018-06-05 |
4 |
B |
$2.91 |
$12,751 |
D/D |
4,000 |
233,978 |
2.39 |
- |
|
| Finney Michael J. |
Director |
– • – |
2018-06-04 |
4 |
B |
$4.27 |
$4,270 |
D/D |
1,000 |
229,978 |
2.31 |
- |
|
| Tucker Sean |
Chief Scientific Officer |
• – – |
2018-03-12 |
4 |
OE |
$6.49 |
$13,064 |
D/D |
2,013 |
47,653 |
|
- |
|
| Finney Michael J. |
Director |
– • – |
2018-02-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,818 |
230,796 |
|
- |
|
| Markham Richard J |
Director |
– • • |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,793,670 |
30,793,670 |
|
- |
|
| Care Capital Offshore Investments Iii Lp |
10% Owner |
– – • |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,793,670 |
30,793,670 |
|
- |
|
| Finney Michael J. |
Director |
– • – |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
228,978 |
228,978 |
|
- |
|
| Leschly Jan |
Director |
– • • |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,793,670 |
30,793,670 |
|
- |
|
| Tucker Sean |
Chief Scientific Officer |
• – – |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
34,448 |
25,388 |
|
- |
|
| Tucker Sean |
Chief Scientific Officer |
• – – |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
45,640 |
45,640 |
|
- |
|
| Colonnese Mark P |
Chief Financial Officer |
• • – |
2016-02-09 |
4 |
B |
$1.40 |
$9,847 |
D/D |
7,000 |
7,000 |
2.74 |
- |
|
| Patti Joseph M |
CEO |
• • – |
2015-09-25 |
4 |
B |
$1.85 |
$9,338 |
D/D |
5,000 |
126,128 |
2.81 |
- |
|
| Plumb Russell H |
Executive Chairman |
• • – |
2015-09-16 |
4 |
D |
$2.49 |
$30,229 |
D/D |
(12,140) |
203,213 |
|
- |
|
| Fox James |
Director |
• • – |
2015-08-11 |
4 |
A |
$2.49 |
$6,225 |
D/D |
2,500 |
2,500 |
|
- |
|
| Vanlent Anne |
Director |
• • – |
2015-06-22 |
4 |
B |
$2.20 |
$76,892 |
D/D |
35,000 |
35,000 |
2.39 |
- |
|
| Fox James |
Director |
• • – |
2015-06-10 |
4/A |
B |
$2.03 |
$142,100 |
I/I |
70,000 |
100,614 |
2.66 |
- |
|
187 Records found
|
|
Page 7 of 8 |
|
|
0.08 (7.98%) 
